18F-4FMFES and 18F-FDG PET/CT in ER+ endometrial carcinomas: preliminary report
Michel Paquette & Eric E Turcotte et al. · 2021-08-19
This article reports the preliminary results of a phase II clinical trial investigating the use of the estrogen receptor (ER)-targeting PET tracer 4-fluoro-11β-methoxy-16α-